Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML
- 15 March 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (6), 3173-3182
- https://doi.org/10.1182/blood-2007-05-092510
Abstract
Activating mutations of the FMS-like tyrosine kinase-3 (FLT3) receptor occur in approximately 30% of acute myeloid leukemia (AML) patients and, at least for internal tandem duplication (ITD) mutations, are associated with poor prognosis. FLT3 mutations trigger downstream signaling pathways including RAS-MAP/AKT kinases and signal transducer and activator of transcription-5 (STAT5). We find that FLT3/ITD mutations start a cycle of genomic instability whereby increased reactive oxygen species (ROS) production leads to increased DNA double-strand breaks (DSBs) and repair errors that may explain aggressive AML in FLT3/ITD patients. Cell lines transfected with FLT3/ITD and FLT3/ITD-positive AML cell lines and primary cells demonstrate increased ROS. Increased ROS levels appear to be produced via STAT5 signaling and activation of RAC1, an essential component of ROS-producing NADPH oxidases. A direct association of RAC1-GTP binding to phosphorylated STAT5 (pSTAT5) provides a possible mechanism for ROS generation. A FLT3 inhibitor blocked increased ROS in FLT3/ITD cells resulting in decreased DSB and increased repair efficiency and fidelity. Our study suggests that the aggressiveness of the disease and poor prognosis of AML patients with FLT3/ITD mutations could be the result of increased genomic instability that is driven by higher endogenous ROS, increased DNA damage, and decreased end-joining fidelity.Keywords
This publication has 56 references indexed in Scilit:
- Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factorsThe Journal of cell biology, 2006
- Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathwaysBlood, 2006
- Direct Involvement of the Small GTPase Rac in Activation of the Superoxide-producing NADPH Oxidase Nox1Published by Elsevier BV ,2006
- Histone Deacetylase Inhibitors (HDI) Cause DNA Damage in Leukemia Cells: A Mechanism for Leukemia-Specific HDI-Dependent Apoptosis?Molecular Cancer Research, 2006
- DNA double strand breaks (DSB) and non-homologous end joining (NHEJ) pathways in human leukemiaCancer Letters, 2003
- Activation of Ras cascade increases the mitochondrial enzyme content of respiratory competent yeastBiochemical and Biophysical Research Communications, 2002
- Increased error-prone non homologous DNA end-joining – a proposed mechanism of chromosomal instability in Bloom's syndromeOncogene, 2002
- Vanadate-induced activation of activator protein-1: role of reactive oxygen speciesCarcinogenesis: Integrative Cancer Research, 1999
- Reactive oxygen species and silica‐induced carcinogenesisJournal of Toxicology and Environmental Health, Part B, 1998
- Regulation of the transcription factors NF-κB and AP-1 by redox changesChemico-Biological Interactions, 1994